Related Experiment Videos
Beta7 integrins contribute to skin graft rejection
Xueying Sun1, Haiquan Qiao, Jinyang Shi
1Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Science, University of Auckland, 85 Park Road, Grafton, New Zealand.
Transplantation
|November 20, 2002
Summary
Beta7 integrins play a key role in T-cell mediated skin inflammation and allograft rejection. Blocking beta7 integrins significantly delayed skin allograft rejection in mice, highlighting their therapeutic potential.
Area of Science:
- Immunology
- Transplantation Biology
- Dermatology
Background:
- Integrins alpha4beta7 and alphaEbeta7 are known to mediate T-cell epidermotropism in skin inflammation.
- The specific role of beta7 integrins in skin allograft rejection remained to be elucidated.
Purpose of the Study:
- To investigate the contribution of beta7 integrins to the process of skin allograft rejection.
- To assess the impact of blocking beta7 integrins on skin allograft survival.
Main Methods:
- Utilized wild-type and beta7 gene knockout mice for allogeneic skin transplantation models.
- Administered anti-integrin beta7 subunit monoclonal antibody (mAb) to block beta7 integrin function in recipient mice.
Main Results:
- Skin allograft survival was significantly prolonged (6-7 days) in beta7 gene knockout recipients and in wild-type recipients treated with anti-beta7 mAb.
- No significant prolongation of skin allograft survival was observed when beta7 was absent or blocked in the recipient SJL/J mice.
Conclusions:
- Beta7 integrins are critical mediators of T-cell epidermotropism and contribute significantly to skin allograft rejection.
- Targeting beta7 integrins may represent a viable strategy to improve skin allograft survival.